Bipolar Disorder News

• Fewer Teens Giving Birth, but Cases Are More Complex Rates of obesity, mental health conditions, diabetes, and delivery complications have increased among teens giving birth.
  Medscape Medical News, May 23, 2022
• Multiple Mental Health Woes? Blame It on Genetics A genetic analysis of 11 major psychiatric disorders offers new insight into why comorbid mental illnesses are the norm, not the exception.
  Medscape Medical News, May 23, 2022
• Neuropsychiatric Risks of COVID: New Data The risk of new-onset neuropsychiatric illness after severe COVID-19 is substantial but appears similar to other severe respiratory infections.
  Medscape Medical News, May 11, 2022
• Medical Home Model Improves Mental Health Treatment Strategy also kept mental health patients out of hospitals, a new study found.
  Medscape Medical News, April 29, 2022
• Schizophrenia Raises Risk of Inflammatory Bowel Disease In support of gut-brain interactions, a large study finds a greater than threefold increased risk of new-onset IBD in patients with schizophrenia.
  Medscape Medical News, April 28, 2022
• High Suicide, Depression Risks for Patients With Cancer Two comprehensive studies provide strong evidence of the psychological impact cancer diagnoses and treatment can have on patients and reveal the need to ramp up mental health services.
  Medscape Medical News, April 25, 2022
• Alcohol Dependence Drug the Next Anti-Anxiety Med? An FDA-approved medication used to treat chronic alcohol dependence appears to reduce anxiety, preclinical research shows.
  Medscape Medical News, April 21, 2022
• Mental Illness Tied to COVID-19 Breakthrough Infection COVID-vaccinated adults with psychiatric illness are at heightened risk for breakthrough infections and should be prioritized for booster shots.
  Medscape Medical News, April 20, 2022
• Buccal Patches and Films Could Make Prescriptions Easier to Take Researchers are developing new ways of administering drugs that are easier, more convenient, could work faster and have fewer side effects.
  WebMD Health News, April 19, 2022
• Alert FDA Okays First Sublingual Med for Agitation in Schizophrenia, BD The FDA has approved dexmedetomidine (IGALMI, BioXcel Therapeutics) sublingual film for the acute treatment of agitation associated with schizophrenia or bipolar disorder in adults.
  FDA Approvals, April 08, 2022
• Hotspots for Mental Illnesses Pinpointed A geospatial investigation of more than 15,000 people has uncovered clusters of mental illness that hint at genetic and environmental factors contributing to disease.
  First Look, April 06, 2022
• Microdosing Psychedelics: Untapped Potential in Psychiatry? As interest in psychedelics as therapy grows in psychiatry, so does the trend in microdosing.
  Medscape Medical News, March 30, 2022
• Psychotropic Med Use Tied to 'Striking' Post-COVID Dementia Risk Use of psychotropic medication prior to contracting COVID-19 illness is linked to an increased risk for dementia in the year following the illness.
  Medscape Medical News, March 29, 2022
• Common Eye Disorder in Children Tied to Mental Illness Misaligned eyes in children are associated with an increased prevalence of mental illness, results of a large study suggest.
  Medscape Medical News, March 18, 2022
• New Tool Cuts CVD Risk in Patients With Serious Mental Illness A new personalized electronic clinical decision tool that is based in the primary care setting shows promise in reducing the risk of cardiovascular disease for patients with serious mental illness.
  Medscape Medical News, March 18, 2022
• Major Mental Illness Linked to Higher CVD Risk, Even in Young Serious mental illnesses like bipolar disorder and schizophrenia are associated with a higher risk of cardiovascular disease, with even greater risk seen among younger age groups.
  Medscape Medical News, March 12, 2022
• HIV and Schizophrenia: Partners in Disparities Patients with serious mental health issues and HIV are falling through the cracks.
  Medscape Medical News, March 10, 2022
• Post-Stroke Cognitive Impairment and Brain Disconnectivity Linked Data from a cross-sectional study shows added predictive value of altered structural brain network perturbations for cognitive impairment beyond the focal lesion size and location in post-stroke patients.
  First Look, March 04, 2022
• Sublingual Dexmedetomidine May Rapidly Calm Bipolar Agitation An investigational, self-administered, orally dissolving film formulation of dexmedetomidine rapidly relieves agitation in patients with bipolar disorder, new research suggests.
  Medscape Medical News, February 28, 2022
• Combination Antidepressant Treatment Outperforms Monotherapy Combining a reuptake inhibitor with presynaptic alpha2-autoreceptors significantly improves treatment outcomes for depression vs monotherapy, a meta-analysis suggests.
  Medscape Medical News, February 16, 2022